BILOXI, Miss., April 11, 2016 — A new USDA analysis of the Food and Drug Administration’s import refusals report reveals that the FDA rejected tens of thousands of imported seafood shipments because they were unfit for human consumption.
From 2005 to 2013, nearly 18,000 shipments were refused entry into the United States for containing unsafe levels of “filth,” veterinary drug residues and Salmonella, which is responsible for thousand hospitalizations per year and hundreds of deaths. “Filth” is a catchall term used to describe anything that shouldn’t be in food—like rat feces, parasites, illegal antibiotics and glass shards.
The USDA summarized their findings by saying, "The safety of imported seafood clearly continues to be of significant concern, based on the number of shipments refused by FDA."
Currently, the majority of all food refusals are seafood products; while the FDA is responsible for ensuring the safety of any food imported from foreign countries, they only have the manpower to inspect less than 1 percent of the 1.2 billion pounds of shrimp entering into the country each year.
The American Shrimp Processors Association (ASPA), a group representing the US Gulf and Southeast Atlantic Coast shrimp fishing industry, has expressed great concern over the findings. Dr. David Veal, the President of ASPA, was quoted as saying, “This issue goes beyond the FDA; I don’t think it’s unreasonable to expect food suppliers to take some responsibility for the health and safety of their products.” While there are a few more FDA inspectors now than a couple years ago, the ratio of shipments to inspectors is still impossibly high. Veal continued, “We hope shrimp exporters will take a more proactive role in assuring that suppliers adhere to laws designed to protect the people who buy their products.”
Shrimp is the most popular seafood in the United States, with the average person consuming more than four pounds of shrimp per year. Worryingly, 90 percent, or 3.6 of those pounds, will be imports from countries like China, Indonesia and Thailand, who routinely distribute shrimp that the FDA ends up refusing.
According to the report, Indonesia and Thailand account for about a fifth of shrimp refusals, and they’re also two of the largest exporters of shrimp to the United States. Moreover, while the report contains information through 2013, in more recent years other countries like India have greatly increased the amount of shrimp they export; in 2015, 297 million pounds of Indian shrimp was turned away.
While information is unavailable on the total number of FDA seafood inspections performed yearly, it is safe to assume that with the extremely low rates of inspection, Americans are consuming imported shrimp that is fundamentally unfit for consumption.
Safety and taste-conscious shrimp buyers are encouraged to purchase wild-caught domestic shrimp, which has demonstrably fewer bacterial and chemical contaminants, and is an important historic industry supporting millions of American jobs. Dr. Veal closed by saying; “Don’t wait until you get sick to start ask questions about where your shrimp is coming from. Things aren’t going to change unless more people realize the gamble they’re taking by eating imported shrimp.”
The American Shrimp Processors Association (ASPA), based in Biloxi, Mississippi, was formed in 1964 to represent and promote the interests of the domestic, U.S. wild-caught, warm water shrimp processing industry along the Gulf and South Atlantic with members from Texas to North Carolina. We are the collective voice of the industry, and our focus is to promote the interests of shrimp processors, other segments of the U.S. domestic wild-caught warm water shrimp industry and the general public.


Trump Administration Seeks Court Pause to Reinstate 10% Global Tariffs
Alibaba Stock Surges After Strong Q4 Earnings Boosted by AI and Cloud Growth
DOJ May Drop Gautam Adani Fraud Charges Amid $10 Billion U.S. Investment Plan
Judge Rules Use of Military Lawyers in Civilian Prosecutions Is Lawful
Arcadia Mayor Eileen Wang Pleads Guilty in China Foreign Agent Case
Coles “Down Down” Ruling Sparks Fresh Scrutiny of Australian Supermarket Pricing
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention
Applied Materials Forecasts Strong Q3 Revenue as AI Chip Demand Accelerates
Kuaishou Stock Jumps on Kling AI IPO Plans and $20 Billion Valuation
Asia-Pacific Banks Brace for Rising Credit Risks Amid Iran Conflict
BlackRock-Led GCC Infrastructure Partnership Targets $30 Billion Investment
Nike Tariff Refund Lawsuit Sparks Consumer Backlash Over Price Increases
Honda Annual Loss Deepens as U.S. Tariffs and EV Costs Weigh on Earnings
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident
Trump Administration Files Fraud Charges Against Southern Poverty Law Center Over Informant Payments
Comey Faces Charges Over Instagram Post as Free Speech Debate Intensifies
OpenAI Finds No Evidence of User Data Breach in TanStack npm Supply-Chain Attack 



